Author:
Harrington Rachel,Lee Edward,Yang Hongbo,Wei Jin,Messali Andrew,Azie Nkechi,Wu Eric Q.,Spalding James
Funder
Astellas Pharma Global Development
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference38 articles.
1. HCUPnet: National and regional estimates on hospital use for all patients from the HCUP National Inpatient Sample (NIS). 2013 [cited 2015 November 30, 2015]. Available from: http://hcupnet.ahrq.gov/ .
2. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011;20(121):156–74.
3. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32(3):358–66.
4. Perkhofer S, Lass-Florl C, Hell M, et al. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents. 2010;36(6):531–6.
5. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34(7):909–17.